A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

October 16, 2019

Study Completion Date

October 16, 2019

Conditions
SpondylarthritisPsoriatic ArthritisAnkylosing Spondylitis (AS)
Trial Locations (14)

107023

State Clinical policlinic /ID# 154374, Moscow

111123

Central Research Institute /ID# 154375, Moscow

115522

Research Institute of Rheum /ID# 154378, Moscow

117041

Advisory-diagnostic Hospital /ID# 154382, Moscow

119049

Clinical Hospital No.1 n.a. N.I.Pirogov /ID# 154379, Moscow

State Clinical Hospital /ID# 154373, Moscow

150000

Yaroslavi State Medical Univer /ID# 154383, Yaroslavl

153040

Ivanovo Regional Clinical Hosp /ID# 167028, Ivanovo

185019

GBUZ Republican Hospital /ID# 167029, Petrozavodsk

191015

Nort-Western State Medical Uni /ID# 154376, Saint Petersburg

214025

Smolensk station JSC Russian R /ID# 167027, Smolensk

300053

Tula Regional Clinical Hospita /ID# 155539, Tula

628011

Institution KhMAO-Ugra /ID# 154381, Khanty-Mansiysk

650066

Kemerovo Regional Clinical Hospital n.a. S.V. Belyaev /ID# 167025, Kemerovo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY